do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation It's the first in a class of drugs called Can dipeptidyl peptidase‑4 (DPP‑4) inhibitors
Description
We however think that GLP-1RAs should be avoided in people with HF with reduced ejection fraction until robust evidence of benefit is generated in this group
Patients with a history of pancreatitis were excluded from trials, so it is unknown if they are at greater risk

Hypertension with diabetes mellitus: Physiology and pathology
This addresses a key pathophysiological driver of type 2 diabetes and improves multiple metabolic parameters

In conclusion, the role of GLP-1RAs in the management of DR remains a nuanced and evolving topic